Table 3.
Recent studies using genetic animal models to investigate the role of MKPs in hepatic metabolism
| Gene/Prote in | Subcellular Localization | Substrate Specificity | Genetic manipulation/Other strategies | Phenotype in knock-out mouse models | Hepatic MKP expression in obesity | References |
|---|---|---|---|---|---|---|
| MKP-1 (DUSP1) | Nuclear | JNK, p38α/β MAPK | Leptin receptor-deficient (db/db) mice lacking MKP-1 | db/db;mkp-1−/− mice exhibit enhanced hepatic β-oxidation and are protected from hepatic steatosis. | Undetermined | [41] |
| MKP-1 (DUSP1) | Nuclear | JNK, p38 α/β MAPK | MKP-1 liver- specific knock-out mice | MKP-1 liver- specific KO mice exhibit hepatic insulin resistance and are protected from the development of hepatic steatosis by MKP-1 to regulating FGF21. | Overexpression of MKP-1 in obesity | [25] |
| MKP-3 (DUSP6) | Cytosolic | ERK | MKP-3 whole-body knock-out mice | Resistant to diet-induced obesity, protection from hepatic steatosis, increased energy expenditure, improved systemic insulin sensitivity | Undetermined | [49] |